Drug intelligence / Profile preview

GelVac HPV vaccine

Development stage
Discontinued
Lead developer
DelSite Biotechnologies
Modality
Hydrogel Systems → Drug Delivery Systems, Vaccines & Immunotherapeutics
Administration
Intranasal, Intramuscular
01

Overview

GelVac HPV vaccine is an investigational vaccine developed by DelSite Biotechnologies for the prevention of Human Papillomavirus (HPV) infection. It utilizes the proprietary GelVac delivery platform, which is based on the GelSite polymer—a high molecular weight ionic polysaccharide. This technology allows the vaccine to be formulated as a nasal powder or a reconstituted injection. A significant advantage of this platform is its ability to stabilize vaccines at room temperature, potentially eliminating the need for cold chain storage. The formulation is designed to be preservative-free and adjuvant-free, relying on the polymer's properties for delivery and potentially enhanced mucosal immunity when administered intranasally.

Brand names
GelVac

Beyond the preview

Go deeper on GelVac HPV vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GelVac HPV vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call